Bromoperidol, a new potent neuroleptic of the butyrophenone series. Comparative pharmacology of bromoperidol and haloperidol.
D000284:Administration, Oral; D000661:Amphetamine / Q000037:antagonists & inhibitors; D000818:Animals; D001058:Apomorphine / Q000037:antagonists & inhibitors; D001362:Avoidance Learning / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects; D001763:Blepharoptosis / Q000139:chemically induced; D001835:Body Weight / Q000187:drug effects; D001966:Bromine / Q000008:administration & dosage / Q000494:pharmacology; D002090:Butyrophenones / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D002375:Catalepsy / Q000139:chemically induced; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004597:Electroshock; D005247:Feeding Behavior / Q000187:drug effects; D005260:Female; D005508:Food Deprivation; D006220:Haloperidol / Q000494:pharmacology* / Q000633:toxicity; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D051381:Rats; D013997:Time Factors
D002090:Butyrophenones; D000661:Amphetamine; D006220:Haloperidol; D001058:Apomorphine; D001966:Bromine; D009638:Norepinephrine